HOUDE LOVAS KATRINA 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Jun 1, 2023
Insider Transaction Report
Form 4
HOUDE LOVAS KATRINA
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-31+9,474→ 32,170 total - Exercise/Conversion
Restricted Stock Unit
2023-05-31−9,474→ 0 total→ Common Stock (9,474 underlying)
Footnotes (2)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]The restricted stock units vested on May 31, 2023.